In Pakistan, there is a notable lack of regulations on the quality of assistive products (APs) and assistive technology (AT) services. The absence of comprehensive quality standards and regulatory mechanisms results in the provision of sub-standard products and services, leading to ineffective products, dissatisfaction among users, product abandonment, and even harm to the health and well-being of users. While regulatory bodies overseeing drugs and medical devices exist, such as the Drug Regulatory Authority of Pakistan (DRAP) and the Pakistan Standards and Quality Control Authority (PSQCA), they do not provide comprehensive quality standards for APs and AT services.
To address these challenges, ReLAB-HS supported key stakeholders to convene a policy roundtable, generating context-specific solutions and formulating key recommendations.
Paving the path for quality assistive products and services in Pakistan